Biology of Inflammation in Crohn's Disease: Mechanisms of Action of Anti-TNF-αAlpha Therapy
Several recent trials of intravenously administered antitumour necrosis factor-alpha (TNF-α) monoclonal antibody have shown dramatic responses among patients with Crohn’s disease. These results indicate a primary role for TNF-αin the mediation of altered mucosal immune function in this disease. Clin...
Saved in:
Main Author: | Stephan R Targan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2000-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2000/409396 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renal Cell Carcinoma in Fistulizing Crohn’s Disease Patient Who Received Anti-TNF α Therapy
by: Abdullah Mohammed Albishi, et al.
Published: (2021-01-01) -
Antitumor Necrosis Factor-Alpha (TNF-α) Infliximab-Induced Pleural Effusion and Pericarditis in Crohn’s Disease
by: Ashley Fonseca, et al.
Published: (2021-01-01) -
Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus
by: Ignacio Marin-Jimenez, et al.
Published: (2024-01-01) -
Biological Treatments in Behçet’s Disease: Beyond Anti-TNF Therapy
by: Francesco Caso, et al.
Published: (2014-01-01) -
Intestinal Tuberculosis Masquerading as Crohn’s Disease? A Case of Disseminated Tuberculosis after Anti-TNF Therapy for Suspected Crohn’s Disease
by: Alexander P. Abadir, et al.
Published: (2019-01-01)